SD, IL-13 Production Rate in IPF

Clinical trial NCT00532233 · COMPLETED

Trial details

NCT number: NCT00532233
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2007-09-01
Primary completion: 2009-06-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.